These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1874917)

  • 21. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen.
    McMahon BJ; Parkinson AJ; Helminiak C; Wainwright RB; Bulkow L; Kellerman-Douglas A; Schoenberg S; Ritter D
    Gastroenterology; 1992 Aug; 103(2):590-4. PubMed ID: 1386048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of the DiaSorin LIAISON(®) anti-HBs II for the detection of hepatitis B surface antibodies: comparison with the Abbott Architect anti-HBs assay.
    Kinn S; Akhavan S; Agut H; Thibault V
    J Clin Virol; 2011 Apr; 50(4):297-302. PubMed ID: 21330194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of hepatitis B surface antibody by an automated microparticle enzyme immunoassay.
    Ostrow DH; Edwards B; Kimes D; Macioszek J; Irace H; Nelson L; Bartko K; Neva J; Krenc C; Mimms L
    J Virol Methods; 1991 May; 32(2-3):265-76. PubMed ID: 1874919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years.
    Da Villa G; Peluso F; Picciotto L; Bencivenga M; Elia S; Pelliccia MG
    Vaccine; 1996 Nov; 14(16):1503-5. PubMed ID: 9014290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.
    Junqueira AL; Tavares VR; Martins RM; Frauzino KV; Silva AM; Rodrigues IM; Minamisava R; Teles SA
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):113-6. PubMed ID: 21340365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the fully automated Cobas Core enzyme immunoassay for the quantitation of antibodies against hepatitis B virus surface antigen.
    Doche C; Thomé M; Dimet I; Bienvenu J
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):365-8. PubMed ID: 8704055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Requirement of standardizing anti-HBs assay methods in Japan for HBV infection-preventing strategy--discrepancy of anti-HBs measurements among three different kits widely used in Japan].
    Ogata N
    Rinsho Byori; 2006 Sep; 54(9):960-5. PubMed ID: 17063878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of the test for antibody to hepatitis B surface antigen--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Sep; 42(36):707-10. PubMed ID: 8361466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Persistence of antibodies against hepatitis B surface antigens after vaccination against hepatitis B].
    Jilg W; Schmidt M; Zachoval R; Deinhardt F
    Dtsch Med Wochenschr; 1985 Feb; 110(6):205-9. PubMed ID: 3967610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunoassay inhibition method for confirming the specificity of positive hepatitis B surface antigen reactions and for survey of antibodies to the antigen.
    Forghani B; Schmidt NJ; Lennette EH
    Vox Sang; 1977; 32(3):125-30. PubMed ID: 857418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
    Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
    J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A chemiluminescent, microparticle-membrane capture immunoassay for the detection of antibody to hepatitis B core antigen.
    Wolf-Rogers J; Weare JA; Rice K; Robertson EF; Guidinger P; Khalil OS; Madsen G
    J Immunol Methods; 1990 Oct; 133(2):191-8. PubMed ID: 2230137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
    Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of two testing methods to determine hepatitis B surface antibody response to hepatitis B vaccine among health-care workers.
    Racela LS; Tegtmeier GE; Hodges GR; Reed JS
    Am J Clin Pathol; 1986 Oct; 86(4):527-9. PubMed ID: 2945426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.